Laboratory tests in the diagnosis of the chronic pancreatic diseases

Elman R, Arneson N, Graham F. Value of blood amylase estimations in the diagnosis of pancreatic disease. Arch Surg 1979;19:943–965. Tait AD, Maniolos K, Duncombe VM, Davis AE. Serum pancreatic isoamylase estimation by the inhibitor method as a diagnostic test for chronic pancreatitis. Aust NZ J Med 1984;14:600–605. Lesi C, Melzi D'Eril GV, Paresi F, et al. Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis. Clin Biochem 1985;19:235–238. Kameya A, Hayakawa T, Noda A, Kondo T. Differential determination of serum iso-amylase using amylase inhibitor and its clinical application. Am J Gastroenterol 1983;18:791–795. Dreiling DA, Richmann A. Evaluation of provocative blood enzyme tests employed in diagnosis of pancreatic disease. Arch Int Med 1954;94:197–213. Zieve L. Clinical value of determinations of various pancreatic enzymes in serum. Gastroenterol 1964;46:62–67. LoGiudice JA, Geenen JE, Hogan WJ, Dodds WJ. Efficacy of the morphine prostigmine test for evaluating patients with suspected papillary stenosis. Dig Dis Sci 1979;24:455–458. Kim DK, Schwartz MK, Sherlock P. The two-stage provocative test for pancreatic disease by serum enzyme measurements. Surg Gynae Obs 1980;150:49–53. O'Donnell MD, FitzGerald O, McGeeney KF. Differential serum amylase determination by use of an inhibitor and design of a routine procedure. Clin Chem 1977;23:560–566. Rammeloo T, Van Haard PMM, Beunis MH. Two serum pancreatic isoamylase determinations compared. Clin Chem 1982;28:145–149. Ellis C, Koehler DF, Eckfeldt JH, Levitt MD. Evaluation of an inhibitor assay to determine serum amylase distribution. Dig Dis Sci 1982;27:897–890. Gersten M, Bank S, Lendvai S. Failure of inhibitor assay to determine isoamylase distribution. Dig Dis Sci 1979;24:990–992. Mifflin TE, Benjamin DC, Burns DE. Rapid quantitative, specific measurement of pancreatic amylase in human serum with the use of a monoclonal antibody. Clin Chem 1985;31:1283–1288. Koehler DF, Eckfeldt JH, Levitt MD. Diagnostic value of routine isoamylase assay of hyperamylasaemic serum. Gastroenterol 1982;82:887–890. Leclerc P, Forest J.C. Variations in amylase isoenzymes and lipase during acute pancreatitis and other disorders causing hyperamylasaemia. Clin Chem 1982;29:1020–1023. Fahrenkrug J, Staun-Olsen P, Magid E. Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis. Clin Chem 1981;27:1655–1657. Massey MH. Efficiency in the diagnosis of acute pancreatitis increased by improved electrophoresis of amylase iso-enzyme P3 on cellulose acetate. Clin Chem 1985;31:70–75. Skude G, Eriksson S. Serum isoamylases in chronic pancreatitis. Scand J Gastroenterol 1976;11:525–527. Skude G, Ihse I. Isoamylases in pancreatic carcinoma and chronic pancreatitis. Scand J Gastroenterol 1977;12:53–57. Lankisch PG, Manthey G, Otto J. et al. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982;25:211–216. Johnson SG, Levitt MD. Relation between serum pancreatic isoamylase concentration and pancreatic exocrine function. Dig Dis Sci 1978;23:914–918. Kelleher J, Losowsky MS, Ruddel WSJ, Mitchell CJ, McMahon MJ, Hamillton I. Assessment of a rapid pancreatic isoamylase assay as a screening test for chronic pancreatic disease. Br Med J 1983;18:791–795. Lankisch PG, Koop H, Otto J. Estimation of serum pancreatic amylase: its role in the diagnosis of exocrine pancreatic insufficiency. Am J Gastroenterol 1986;81:365–368. Warshaw AL, Kang-Hynn L. Aging changes of pancreatic isoamylases and the appearance of ‘old amylase’ in the serum of patients with pancreatic pseudocyts. Gastroenterol 1980;79:1246–1251. Hubbard VS, Wolf RD, Lester LA, Egge AC. Diagnostic and therapeutic applications of bentiromide screening for exocrine pancreatic insufficiency in patients with cystic fibrosis: comparison with other tests of exocrine pancreatic disease. Dig Dis Sci 1984;29:881–889. Shwachman H, Lebenthal E, Khow KT. Recurrent acute pancreatitis in patients with cystic fibrosis and normal pancreatic enzymes. Paediatrics 1979;55:86–95. Koop H, Lankisch PG, Stockmann F, Arnold R. Trypsin radio immunoassay in the diagnosis of chronic pancreatitis. Digestion 1980;20:151–156. Rinderknecht H, Renner IG, Carmach L. Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas. Gut 1979;20:886–8911. Elias E, Redshaw M, Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 1977;2:66–68. Malvano R, Marchisio M, Massaglia A, Giacosa PA, Zannino M, Andriulli A, Burlina A. Radioimmunoassay of trypsin-like substance in human plasma. Scand J Gastroenterol 1980;15:Suppl 60: 3–10. Masoero G, Andriulli A, Bianco A, Benitti V, Marchetto M, De La Pierre M. Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic disease. Dig Dis Sci 1982; 27:1089–1094. Bonora G, Tomassetti P, Sternini C, Bagnari L, Agostini D, Vezzadini P. Basal and stimulated serum immunoreactive trypsin in normal subjects. Scand J Gastroenterol 1980;15:Suppl. 60:11–14. Amman RW, Pei P, Satz N, Woodtli W. Variations with age of serum immunoreactive trypsin: higher reference ranges in ‘healthy’ elderly people. Klin Woch 1982;60:243–246. Crossley JR, Elliot RB, Smith PA. Dried blood spot screening for cystic fibrosis in the new-born. Lancet 1979;1:472–474. King DN, Walsh MP, Heeley AF, Kuzemko JA. Sensitive trypsin assay for dried blood specimens as a screening procedure for the early detection of cystic fibrosis. Lancet 1979;2:1217–1219. Antonuci F, Vezzadini P, Adorati M, Bonora G, Messa P, Montanaro D, Miori G. Serum trypsin-like immunoreactivity and secondary hyperparathyroidism in renal failure. Scand J Gastroenterol 1980;15:Suppl 60:53–57. Ruddel WSJ, Mitchel CJ, Hamilton I, Leck JP, Kelleher J. Clinical value of serum immunoreactive trypsin concentration. Br Med J 1981;1:1429–1432. Steinberg WM, Anderson KK. Serum trypsinogen in diagnosis of chronic pancreatitis. Dig Dis Sci 1984;29:988–993. Braganza JM. Does your patient have pancreatic disease? J Roy Coll Physicians Lond 1982;16:13–22. Heij HA, Obertop H, Schmitz PIM, Van Blankenstein M, Westbroek DL. Evaluation of the secretin-cholecystokinin test for chronic pancreatitis by discriminant analysis. Scand J Gastroenterol 1986;21:35–40. Ensley L, Nybol-Andersen B, Fahrenkrug J, Magid E, Thorsgaard-Pedersen N. Serum immunoreactive trypsin, pancreatic polypeptide, and pancreatic iso-amylase as diagnostic tests for chronic pancreatitis. Scand J Gastroenterol 1984;19:204–208. Andriulli A, Masoero G, Felder M, et al. Circulating trypsin-like immunoreactivity in chronic pancreatitis. Dig Dis Sci 1981;26:532–537. Vaona B, Benini L, Rizzotti R, et al. Serum levels of amylase, lipase and trypsin in patients with chronic pancreatitis and pancreatic cancer. Ital J Gastroenterol 1985;17:139–142. Jacobson DG, Curington C, Connery K, Toskes PP. Trypsin-like immunoreactivity as a test for pancreatic insufficiency, New Eng J Med 1984;310:1307–1309. Dandona P, Elias E, Beckett AG. Serum trypsin concentrations in diabetes mellitus. Br Med J 1978;2:1125. Steinberg WM, Goldstein SS, Davis ND, Anderson KK, Shamma'a JM. Predictive value of a low serum trypsinogen. Dig Dis Sci 1985;30:547–551. Lake-Bakaar G, McKavanagh S, Redshaw M, Wood T, Summerfield JA, Elias E. Serum immunoreactive trypsin concentration after a Lundh meal: its value in the diagnosis of pancreatic disease. J. Clin Pathol 1979;32:1003–1008. Adrian TE. Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic disease. Scand J Gastroenterol 1980;15:Suppl 60:15–25. Vezzadini P, Gullo L, Sternini L, Bonora G, Ferri GL, Labo G. Serum immunoreactive trypsin after secretin stimulation in chronic pancreatitis. Scand J Gastroenterol 1980;15:Suppl 60:29–34. Vezzadini P, Gullo L, Sternini L, Bonora G, Ferri GL, Labo G. Serum immunoreactive trypsin response to secretin injection in patients with chronic pancreatitis. Am J Gastroenterol 1984;79:213–216. Burlina A, Rizzotti P, Tonou M, Mastella G. Serum immunoreactive trypsin in cystic fibrosis. Scand J Gastroenterol 1980;15:Suppl 60:35–43. Basso N, Giri S, Improta G, Leroche F, Melchiosi Perioco M, Speranza V. External pancreatic secretion after bombesin infusion in man. Gut 1975;16:994–948. Andriulli A, Masoero G, Fico O, Zago P, Marchetto M. Evocative test of serum pancreatic enzymes to bombesin in chronic pancreatitis. Am J Gastroenterol 1986;81:562–565. Severi C, Bellentini S, Annibale B, et al. Effect of bombesin on plasma trypsin-like immunoreactivity in normal subjects and in patients with and without pancreatic steatorrhoea. Ital J Gastroenterol 1983;15:132–134. Masoero G, Andriulli A, Santini B, et al. Serum trypsin-like immunoreactivity in cystic fibrosis. Am J Dis Child 1983;137:167–170. Cleghorn G, Benjamin L, Corey M, Forstner G, Dati F, Durie P. Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis. J Paed 1985;107:337–381. Durie PR, Largman C, Brodrick JW, et al. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction. Paed Res 1981;15:1351–1355. Durie PR, Forstner GG, Gaskin KJ, et al. Elevated serum immunoreactive cationic trypsinogen in acute malnutrition: evidence of pancreatic damage. J Paed 1985;106:233–238. Toskes PP. Serum trypsin as a test for chronic pancreatitis. Gastroenterol 1982;82:155–156. Lake-Bakaar G, McKavanagh S, Summerfield JA. Urinary immunoreactive trypsin excretion: a non-invasive screening test for pancreatic cancer. Lancet 1979;2:878–850. Farini R, Fabris C, Del Favero G, et al. Role of trypsin/creatinine clearance in the differential diagnosis of chronic pancreatic disease. Gastroenterol 1981;81:254–246. Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion 1983;28:114–121. Møller-Petersen J, Klaerke M, Dati F. Evaluation and comparison of cathodic trypsin-like immunoreactivity, pancreatic lipase and pancreatic isoamylase in the diagnosis of acute pancreatitis in 849 consecutive patients with acute abdominal pain. Clin Chim Acta 1986;157:151–166. Fjøsne U, Waldrun HL, Romslo I, Kleveland PM, Johnsen H, Engebretsen LF. Amylase, pancreatic iso-amylase and lipase in serum after endoscopic pancreatography. Acta Med Scand 1986;219:301–304. Largman C, Brodrick JW, Geokas MC, Sischo WM, Johnson JH. Formation of a stable complex between human proelastase-2 and human α1 inhibitor. J Biol Chem 1979;254:8516–8523. Kimura H. Studies on elastase in pancreatic diseases. Jpn J Gastroenterol 1979;78:1985–2016. Satake K, Chung YS, Umeyama K. Serum elastase-1 levels in pancreatic disease. Am J Surg 1982;144:239–242. Murata A, Ogawa M, Fujimoto K, Kitahara T, Kosaki G. Changes in serum immunoreactive pancreatic elastase-1 in acute pancreatitis. Hepatogastroenterol 1982;29:278–280. Umeki S, Satoh T, Ueda S. Alterations in serum pancreatic elastase-1 content in acute and chronic pancreatitis. Comparison with α-amylase activity. J Lab Clin Med 1985;106:578–582. Lesi C, Ruffilli E, De Mutiis R, Faccenda F, Zoni L, Malagutti P. Usefulness of serum elastase-1 in clinical practice. Digestion 1986;35:37. Büchler M, Malfertheimer P, Uhle W, Berger HG. Elastase-1 in acute pancreatitis. Second International Meeting of Pancreatology, Sao Paulo, Brazil 1986;A72. Hamano H, Hayakawa T, Kondo T. Serum immunoreactive elastase in diagnosis of pancreatic cancer. A sensitive marker for pancreatic cancer. Dig Dis Sci 1987;32:50–56. Creutzfeldt W, Schmidt H. Aetiology and pathogenesis of pancreatitis (current concepts). Scand J Gastroenterol 1970;Suppl 6:47–62. Eskola JU, Nevalainen TJ, Lovgren TN-E. Time-resolved fluoroimmunoassay of human pancreatic phospholipase A2. Clin Chem 1983;20:1777–1780. Hoffman GE, Schmidt D, Bastian B. Bestimmung der Phospholipase A in Serum bei akuter Pankreatitis. J Clin Chem Clin Biochem. 1985;23:582–583. Buchler M, Malfertheimer P, Schadlich H, Nevalainen T, Berger HG. Phospholipase A activity determined the severity of human acute pancreatitis. Digestion 1986;35:11. Larsson LI, Saundler F, Håkansson R. Pancreatic polypeptide, a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia 1976;12:211–226. Adrian TE, Besterman HS, Cook TJ, et al. Mechanism of pancreatic polypeptide release in man, Lancet 1977;1:161–163. Adrian TE, Bloom SR, Bryant MG, et al. Distribution and release of human pancreatic polypeptide. Gut 1976;17:940–944. Owyang C, Scarpello JH, Vinik AI. Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and chronic pancreatitis. Gastroenterol 1982;83:55–62. Linnestad P, Schrumpf E. Pancreatic polypeptide release stimulated by food, secretin and cholecystokinin in chronic pancreatitis. Scand J Gastroenterol 1983;18:385–389. Regan PT, Go VLW, DiMagno EP. Comparison of the effects of cholecystokinin and cholecystokinin-octapeptide on pancreatic secretion, gall-bladder contraction and plasma pancreatic polypeptide in man. J Lab Clin Med 1980;96:743–748. Greenberg GR, McCloy RF, Chadwick VS, et al. Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Am J Dig Dis 1979;24:11–14. Berger D, Crowther RC, Flayel JC, Pek S, Fajans SS. Effect of age on fasting plasma levels of pancreatic polypeptide. J Clin Endocrinol 1978;47:1183–1187. Fink RS, Adrian TE, Margot DH, Bloom SR. Increased plasma pancreatic polypeptide in chronic alcohol abuse. Clin Endocrinol 1983;18:417–421. Mirey E, Jow E, Slavin RE, Tobin F. Pancreatic function and intestinal absorption in chronic alcoholism. Gastroenterol 1970;59:657–664. Cichy Y, Lankisch PG, Arnold R, Creutzfeld W. Evaluation of serum pancreatic polypeptide estimations following hormonal stimulation for the diagnosis of exocrine pancreatic insufficiency. Digestion 1984;30:218–223. Koch MB, Go VLW, DiMagno EP. Can plasma human pancreatic polypeptide be used to detect disease of the exocrine pancreas? Mayo Clin Proc 1985;60:259–265. Adrian TE, Besterman HS, Mallinson CN, Garalotis C, Bloom SR. Impaired HPP release in chronic pancreatitis with steatorrhoea Gut 1979;20:98–101. Besterman HS, Adrian TE, Bloom SR, et al. Pancreatic and gastrointestinal hormones in chronic pancreatitis. Digestion 1982;24:195–208. Anagnostides AA, Cox TM, Adrian TE, Pancreatic exocrine and endocrine response in, chronic pancreatitis. Am J Gastroenterol 1984;79:206–212. Sivi A, Vinik AI, Van Tonder S, and Lund A. Impaired pancreatic polypeptide secretion in chronic pancreatitis. J Clin Endocrinol Metab 1978;47:556–559. Stern A, Davidson GP, Kirubakaran CP, Deutsch J, Smith A, Hansky J. Pancreatic polypeptide secretion: a marker for disturbed pancreatic function, in cystic fibrosis. Dig Dis Sci 1978;47:556–559. Stern, AI, Hansky J. Secretin stimulated pancreatic polypeptide: a test for chronic pancreatitis. Aust NZ J Med 1981;11:351–354. Gaskin K, Gurowitz D, Durie P, Corey M, Levison H, Forstner GG. Improved respiratory prognosis in patients with cystic fibrosis and normal fat absorption J Paed 1982;100:857–862. Adrian TE, McKieran J, Johnstone DI, et al. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterol 1980;79:460–465. Polak JM, Bloom SR, Adrian TE, Heitz PH, Bryant MG, Pearse AGE. Pancreatic polypeptide in insulinomas, gastrinomas, VIPomas and glucagonomas, Lancet 1976;1:328–330. Taylor IL, Walsh JH, Rotter J, Passaro E. Is pancreatic polypeptide a marker for the Zollinger-Ellison syndrome? Lancet 1978;1:845–848.